| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 6.4% | $4,990,444 | 339,486 | The Vanguard Group | 31 Dec 2025 |
As of 31 Dec 2025, 14 institutional investors reported holding 458,163 shares of Coeptis Therapeutics Holdings, Inc. - Common Stock (COEP). This represents 8.6% of the company’s total 5,346,236 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 458,163 | $6,529,335 | +$4,482,731 | $14.25 | 14 |
| 2025 Q3 | 137,620 | $2,402,871 | +$626,917 | $17.46 | 10 |
| 2025 Q2 | 101,909 | $794,900 | -$48,055 | $7.80 | 8 |
| 2025 Q1 | 55,239 | $517,607 | +$437,923 | $9.37 | 8 |
| 2024 Q4 | 8,504 | $44,406 | +$44,406 | $5.50 | 5 |